Duy Do

409 total citations · 1 hit paper
22 papers, 189 citations indexed

About

Duy Do is a scholar working on Economics and Econometrics, Public Health, Environmental and Occupational Health and General Health Professions. According to data from OpenAlex, Duy Do has authored 22 papers receiving a total of 189 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Economics and Econometrics, 4 papers in Public Health, Environmental and Occupational Health and 3 papers in General Health Professions. Recurrent topics in Duy Do's work include Medication Adherence and Compliance (3 papers), Healthcare Policy and Management (3 papers) and Pharmacology and Obesity Treatment (2 papers). Duy Do is often cited by papers focused on Medication Adherence and Compliance (3 papers), Healthcare Policy and Management (3 papers) and Pharmacology and Obesity Treatment (2 papers). Duy Do collaborates with scholars based in United States, Germany and Bangladesh. Duy Do's co-authors include Jason Schnittker, Nicholas L Stucky, Samuel Gratzl, Patricia J. Rodriguez, Charlotte Baker, Ezekiel Emanuel, Ty J. Gluckman, Vincent Zhang, Pascal Geldsetzer and Monica F. Rochman and has published in prestigious journals such as Pain, American Journal of Obstetrics and Gynecology and American Journal of Preventive Medicine.

In The Last Decade

Duy Do

19 papers receiving 181 citations

Hit Papers

Discontinuation and Reinitiation of Dual-Labeled GLP-1 Re... 2025 2026 2025 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Duy Do United States 7 41 33 32 32 24 22 189
Elizabeth A. Vrany United States 9 48 1.2× 63 1.9× 33 1.0× 35 1.1× 55 2.3× 23 274
Erin M. Staab United States 9 98 2.4× 57 1.7× 26 0.8× 15 0.5× 26 1.1× 38 232
C. Catalina-Romero Spain 11 47 1.1× 102 3.1× 30 0.9× 46 1.4× 31 1.3× 23 302
Jonathan Favre France 7 18 0.4× 43 1.3× 18 0.6× 17 0.5× 29 1.2× 15 266
Madalina Jäger Denmark 8 26 0.6× 57 1.7× 41 1.3× 42 1.3× 14 0.6× 16 256
Kerry S. Whittaker United States 10 14 0.3× 36 1.1× 9 0.3× 35 1.1× 31 1.3× 17 296
Paulo Roberto Zimmermann Brazil 9 50 1.2× 63 1.9× 10 0.3× 40 1.3× 52 2.2× 17 323
Mohamed Al‐Kazaz United States 8 14 0.3× 40 1.2× 10 0.3× 18 0.6× 18 0.8× 14 274
Katalin Gémes Sweden 11 15 0.4× 49 1.5× 60 1.9× 23 0.7× 42 1.8× 33 369
Erik R. Vanderlip United States 10 23 0.6× 60 1.8× 18 0.6× 18 0.6× 39 1.6× 19 248

Countries citing papers authored by Duy Do

Since Specialization
Citations

This map shows the geographic impact of Duy Do's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duy Do with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duy Do more than expected).

Fields of papers citing papers by Duy Do

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Duy Do. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duy Do. The network helps show where Duy Do may publish in the future.

Co-authorship network of co-authors of Duy Do

This figure shows the co-authorship network connecting the top 25 collaborators of Duy Do. A scholar is included among the top collaborators of Duy Do based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Duy Do. Duy Do is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Masters, Nina B., et al.. (2026). Delayed or Absent First Dose of Measles, Mumps, and Rubella Vaccination. JAMA Network Open. 9(1). e2551814–e2551814. 1 indexed citations
2.
Rodriguez, Patricia J, et al.. (2025). Shifts in US Pediatric Obesity Treatment After the AAP Guidelines. 1(3). 1–12. 1 indexed citations
3.
Masters, Nina B., et al.. (2025). Early MMR Vaccine Adoption During the 2025 Texas Measles Outbreak. JAMA Network Open. 8(11). e2543002–e2543002. 1 indexed citations
4.
Do, Duy, et al.. (2025). Glucagon-Like Peptide-1 Use and Healthcare Resource Utilization for Depression and Anxiety Among Adults with Type 2 Diabetes: 2019 to 2023. The Journal of Behavioral Health Services & Research. 2 indexed citations
5.
Do, Duy, et al.. (2025). Trends in Incidence of Syphilis Among US Adults from January 2017 to October 2024. American Journal of Preventive Medicine. 3 indexed citations
6.
Gratzl, Samuel, Ahmad Algohary, Hao Lin, et al.. (2025). XComposition: multimodal deep learning model to measure body composition using chest radiographs and clinical data. PubMed. 2(5). umaf035–umaf035. 1 indexed citations
7.
Rodriguez, Patricia J., Vincent Zhang, Samuel Gratzl, et al.. (2025). Discontinuation and Reinitiation of Dual-Labeled GLP-1 Receptor Agonists Among US Adults With Overweight or Obesity. JAMA Network Open. 8(1). e2457349–e2457349. 67 indexed citations breakdown →
10.
Tan-Kim, Jasmine, et al.. (2023). Efficacy of vaginal estrogen for recurrent urinary tract infection prevention in hypoestrogenic women. American Journal of Obstetrics and Gynecology. 229(2). 143.e1–143.e9. 11 indexed citations
11.
Do, Duy, et al.. (2023). Prevalence and Predictors of Multimodal Treatment Among U.S. Adults Newly Diagnosed With ADHD. American Journal of Preventive Medicine. 66(4). 707–716. 3 indexed citations
12.
Do, Duy & Jason Schnittker. (2022). Pharmaceutical Side Effects and the Sex Differences in Depression and Distress. American Journal of Preventive Medicine. 63(2). 213–224. 3 indexed citations
13.
Do, Duy, et al.. (2022). A retrospective analysis of bone loss in tenofovir-emtricitabine therapy for HIV PrEP. International Journal of STD & AIDS. 33(14). 1183–1192. 2 indexed citations
14.
Do, Duy, et al.. (2022). Effects of the COVID-19 Pandemic on Grief: A Prospective Survey Among Community Hospital Next-of-Kin. Journal of Palliative Medicine. 26(5). 653–661. 5 indexed citations
15.
Do, Duy & Pascal Geldsetzer. (2021). Trends in Mail-Order Pharmacy Use in the U.S. From 1996 to 2018: An Analysis of the Medical Expenditure Panel Survey. American Journal of Preventive Medicine. 61(2). e63–e72. 11 indexed citations
16.
Dierkes, Andrew, et al.. (2021). The impact of California's staffing mandate and the economic recession on registered nurse staffing levels: A longitudinal analysis. Nursing Outlook. 70(2). 219–227. 17 indexed citations
17.
Do, Duy. (2020). The impact of Medicare Part D on opioid use among U.S. older adults. Drug and Alcohol Dependence. 212. 108069–108069. 5 indexed citations
19.
Do, Duy. (2020). Trends in the use of medications with insomnia side effects and the implications for insomnia among US adults. Journal of Sleep Research. 29(4). e13075–e13075. 17 indexed citations
20.
Do, Duy & Jason Schnittker. (2020). Utilization of Medications With Cognitive Impairment Side Effects and the Implications for Older Adults’ Cognitive Function. Journal of Aging and Health. 32(9). 1165–1177. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026